August 31, 2011

Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011

SAN DIEGO, Aug. 31, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:

	Stifel Nicolaus 2011 Healthcare Conference
	Date:	Wednesday, September 7, 2011
	Time:	1:30pm Eastern Time (10:30am Pacific Time)
	Place:	Four Seasons Hotel in Boston
	Speaker:	Scott Byrd, SVP & Chief Commercial Officer

	UBS Global Life Sciences Conference
	Date:	Tuesday, September 20, 2011
	Time:	11:30am Eastern Time (8:30am Pacific Time)
	Place:	Grand Hyatt Hotel in New York City
	Speaker:	Ted Schroeder, President & CEO

	JMP Securities Healthcare Conference
	Date:	Wednesday, September 28, 2011
	Time:	9:30am Eastern Time (6:30am Pacific Time)
	Place:	The St. Regis Hotel in New York City
	Speaker:	Ted Schroeder, President & CEO

Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.


Contacts:	William R. LaRue SVP, CFO Cadence Pharmaceuticals, Inc. 858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.

News Provided by Acquire Media

Close window | Back to top

Share this on:
Delicious
Digg
Facebook
LinkedIn
Twitter

What is this?